Cargando…
The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells
British Journal of Cancer (2002) 87, 1340–1340. doi:10.1038/sj.bjc.6600571 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer (2002) 86, 1479–1486. doi:10.1038/sj.bjc.6600297
Autores principales: | Senaratne, S G, Mansi, J L, Colston, K W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408900/ http://dx.doi.org/10.1038/sj.bjc.6600571 |
Ejemplares similares
-
The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells
por: Senaratne, S G, et al.
Publicado: (2002) -
The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
por: Senaratne, Siddhika G, et al.
Publicado: (2002) -
Bisphosphonates induce apoptosis in human breast cancer cell lines
por: Senaratne, S G, et al.
Publicado: (2000) -
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010) -
The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
por: Jagdev, S P, et al.
Publicado: (2001)